Consistent with our results, another recent study showed that the PHD inhibitor enarodustat can counteract diabetes-induced upregulation of fatty acid and amino acid metabolism genes and thus may have protective roles against diabetic kidney disease progression (Hasegawa et al., 2020). The gene discussed is PDC; the disease is diabetic kidney disease.